Western EuropeNorth Africa North AmericaLatin America & CaribbeanSouth-East AsiaEast AsiaMiddle East
Year of Establishment
2020
Company Funding Stage
Seed & Pre-Series
Service Introduction
Medix is a pioneering medical technology company specializing in advanced trauma hemostasis solutions, best known for its proprietary ProClot hemostatic gel and powder across clinical medicine, emergency response, and veterinary care.
For rapid hemorrhage control in both surgical settings and veterinary care
Actively scales international footprint across North America, Southeast Asia, the Middle East, and Africa while securing key regulatory approvals, including FDA clearance.
At which key stages of the project lifecycle are your services appropriately applied?
Feasibility AssessmentFinancing and InsuranceMarket Assessment and Project SelectionRisk Planning
For human/pet use, Gel & Powder & Gauze
Led by a US serial founder, outperforms legacy trauma products. Co-developed with a Med Univ VP. 4 APAC MOUs in Yr 1 with 0 ad spend & + Higher partner margins. Book a 1-on-1!